Rita's laparoscopic resection tool:
This article was originally published in Clinica
Executive Summary
Rita Medical Systems has received US FDA 510(k) clearance to sell a laparoscopic version of its Habib 4X resection device for coagulating tissue during cancer surgery. The radiofrequency ablation-based product, which is used to coagulate a surgical resection plane, facilitates a fast dissection with limited blood loss, claimed the Fremont, California firm. US shipments of the device are expected to take place in the second half of the fourth quarter of 2006, when Rita Medical also plans to CE-mark, and start selling, the product in Europe. A non-laparoscopic version of the device has been commercially available since the third quarter of 2005. The laparoscopic device incorporates technology licensed by Rita Medical from UK firm EMcision.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.